Company · CIK 1434265

# GENMAB A/S

| CIK | [1434265](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001434265) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | Denmark |
| Listed | GMAB (Nasdaq), GNMSF (OTC) |
| First annual or quarterly report | 2020-03-30 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-231777 | IPO Final prospectus | 2019-05-28 | 2019-07-19 | 5 |

## Filings

 8

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-07-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1434265/999999999525002257/9999999995-25-002257-index.htm) Declared effective | 333-288500 | 9999999995-25-002257 |
| 2019-07-19 | [424B4](https://www.sec.gov/Archives/edgar/data/1434265/000104746919004269/0001047469-19-004269-index.htm) Final prospectus | 333-231777 | 0001047469-19-004269 |
| 2019-07-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1434265/999999999519001624/9999999995-19-001624-index.htm) Declared effective | 333-231777 | 9999999995-19-001624 |
| 2019-07-16 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1434265/000104746919004195/0001047469-19-004195-index.htm) Amendment | 333-231777 | 0001047469-19-004195 |
| 2019-07-09 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1434265/000104746919004052/0001047469-19-004052-index.htm) Amendment | 333-231777 | 0001047469-19-004052 |
| 2019-05-28 | [F-1](https://www.sec.gov/Archives/edgar/data/1434265/000104746919003334/0001047469-19-003334-index.htm) Registration filed | 333-231777 | 0001047469-19-003334 |
| 2019-02-05 | [DRS](https://www.sec.gov/Archives/edgar/data/1434265/000091205719000036/0000912057-19-000036-index.htm) Draft made public | 377-02489 | 0000912057-19-000036 |
| 2013-05-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1434265/999999999513001659/9999999995-13-001659-index.htm) Declared effective | 333-188759 | 9999999995-13-001659 |

[All filings of this company](https://equitycapital.markets/filings?cik=1434265) · [CSV](https://equitycapital.markets/filings.csv?cik=1434265)

---
Source page: https://equitycapital.markets/company/1434265 · Data: U.S. SEC EDGAR · CC BY 4.0
